Recent developments in cancer research have highlighted the potential of repurposing existing antiparasitic medications, such as fenbendazole and ivermectin, as alternative cancer therapies. These drugs, traditionally used to treat parasitic infections in animals and humans, respectively, have demonstrated promising anticancer properties in preclinical studies. READ MORE
